Skip to main content
ChemoMetec logo

ChemoMetec — Investor Relations & Filings

Ticker · CHEMM ISIN · DK0060055861 LEI · 213800533NBKECGONO68 CO Manufacturing
Open in API
Filings indexed 538 across all filing types
Latest filing 2020-09-16 Report Publication Anno…
Country DK Denmark
Listing CO CHEMM

About ChemoMetec

https://chemometec.com

ChemoMetec is a global manufacturer specializing in high-precision automated cell counting and analysis instrumentation. The company develops and produces a range of advanced image cytometers and cell density analyzers, including the NucleoCounter® and XcytoMatic® series. These systems provide consistent, reproducible, and accurate cell count and viability data for a wide range of cell types. Key technologies include fluorescence microscopy, which enables trypan blue-free analysis, and specialized consumables designed to minimize human error. ChemoMetec's instruments are designed for regulated environments, offering software solutions compliant with FDA 21 CFR Part 11 and supporting Good Manufacturing Practice (GMP) workflows. The company serves customers in the biotechnology, pharmaceutical, and academic sectors, with applications in cell and gene therapy, cancer research, and bioprocessing.

Recent filings

Filing Released Lang Actions
Fortsat solid vækst og rekordhøjt resultat
Report Publication Announcement Classification · 1% confidence The document is a corporate announcement (Meddelelse nr. 196) from ChemoMetec regarding their 2019/20 Annual Report. While it contains summary financial highlights and key performance indicators, the text explicitly states 'Årsrapport 2019/20 er vedhæftet som bilag til denne meddelelse' (Annual Report 2019/20 is attached as an appendix to this announcement). According to the 'Menu vs Meal' rule, a document that announces the publication of a report and provides it as an attachment is classified as a Report Publication Announcement (RPA). FY 2020
2020-09-16 Danish
Earnings Release 2020
Earnings Release Classification · 1% confidence The document is a short announcement (1318 characters) dated July 6, 2020, titled 'Præcisering af forventninger til omsætning og driftsresultat' (Clarification of expectations for revenue and operating profit). It revises the financial guidance (revenue and EBITDA) for the fiscal year ending June 30, 2020. Crucially, it states that the full 'årsrapport' (annual report) is expected to be published on September 17, 2020. Since this document is a short-form announcement providing updated guidance and explicitly points to a future, more comprehensive report, it fits the definition of an Earnings Release (ER) which covers initial announcements of periodical financial results (key highlights only, in this case, guidance updates). It is not the full report itself (10-K or IR), nor is it a general regulatory filing (RNS) given the specific financial nature of the update. FY 2020
2020-07-06 Danish
Earnings Release 2020
Earnings Release Classification · 1% confidence The document is titled "Præcisering af forventninger til omsætning og driftsresultat" (Clarification of expectations for revenue and operating profit) and provides updated guidance for the fiscal year 2019/20, specifically mentioning revenue and EBITDA figures. This content strongly aligns with an Earnings Release (ER), which typically announces key financial highlights before the full report. However, the document also explicitly states when the full annual report is expected to be published ('ChemoMetecs årsrapport for 2019/20 forventes offentliggjort torsdag den 17. september 2020'). Since this document is a pre-release update on expected results, it fits the definition of an Earnings Release (ER). It is not the full Annual Report (10-K) or the Interim Report (IR). Given its nature as a concise update on financial performance expectations, ER is the most appropriate classification. FY 2020
2020-07-06 Danish
Earnings Release 2020
Earnings Release Classification · 1% confidence The document is a formal announcement (MEDDELELSE NR. 191) dated April 28, 2020, providing an update on the operating result (EBITDA) forecast for the fiscal year 2019/20, citing lower general costs due to COVID-19. It explicitly mentions that the full Q3 2019/20 report is expected to be published on May 7, 2020. This document is not the full quarterly report (IR) itself, nor is it a full annual report (10-K). It is a pre-release announcement of key financial guidance changes, which aligns best with the 'Earnings Release' (ER) category, as it updates expected financial performance before the official release date. Although it is an update rather than the initial release, it concerns the core earnings figures. FY 2020
2020-04-28 English
Earnings Release 2019
Earnings Release Classification · 1% confidence The document is titled "Opjustering af driftsresultat" (Adjustment of operating result) and provides updated financial guidance (EBITDA forecast DKK 82-90 mio. vs. previous DKK 77-83 mio.) for the fiscal year 2019/20, citing lower-than-expected general costs, partly due to COVID-19 travel restrictions. This is a specific announcement regarding financial performance expectations, not the full quarterly or annual report itself. It fits the definition of an Earnings Release (ER) as it announces key financial highlights/revisions before the full quarterly report (which is scheduled for May 7, 2020). The document is short and announces a revision to guidance, which is typical for an ER or a pre-report update. It is not a 10-K (Annual Report), IR (Interim Report), or MDA (Management Discussion & Analysis), as those are comprehensive reports. It is a specific financial update announcement. Q3 2019
2020-04-28 Danish
Major Shareholding Notification 2020
Major Shareholding Notification Classification · 1% confidence The document is titled "Storaktionærmeddelelse" (Major Shareholder Announcement) and explicitly states that Handelsbanken Fonder AB has reduced its holding in ChemoMetec A/S to 4.75% of the share capital, citing §30 of the Danish Capital Markets Act. This directly relates to changes in significant share ownership thresholds. This aligns perfectly with the definition for Major Shareholding Notification (MRQ). The document is short (1212 chars) and contains an attachment link, but the core content is the notification itself, making MRQ more specific than a general RPA or RNS.
2020-04-07 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.